0001209191-21-027683.txt : 20210420 0001209191-21-027683.hdr.sgml : 20210420 20210420195400 ACCESSION NUMBER: 0001209191-21-027683 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210420 FILED AS OF DATE: 20210420 DATE AS OF CHANGE: 20210420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KENYON LAWRENCE A CENTRAL INDEX KEY: 0001230484 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37759 FILM NUMBER: 21839201 MAIL ADDRESS: STREET 1: C/O OUTLOOK THERAPEUTICS, INC. STREET 2: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outlook Therapeutics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 4260 U.S. ROUTE 1 CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 4260 U.S. ROUTE 1 CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 FORMER COMPANY: FORMER CONFORMED NAME: Oncobiologics, Inc. DATE OF NAME CHANGE: 20150804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-20 0 0001649989 Outlook Therapeutics, Inc. OTLK 0001230484 KENYON LAWRENCE A C/O OUTLOOK THERAPEUTICS, INC. 4260 US ROUTE 1 MONMOUTH JUNCTION NJ 08852 1 1 0 0 CEO, Pres, CFO, Treas & Secy Common Stock 2021-04-20 4 P 0 10000 1.83 A 18926 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within a $1.00 range. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. /s/ Lawrence Kenyon 2021-04-20